Damora Therapeutics (DMRA) Treasury Shares (2024 - 2026)
Damora Therapeutics (DMRA) reported Treasury Shares of $957513.0 for Q1 2026, up 9061.05% on a YoY basis from $10452.0 in Q1 2025, and up 12175.81% quarter-over-quarter from $7800.0 in Q4 2025.
Damora Therapeutics (DMRA) Treasury Shares (2024 - 2026) Analysis & Trends
Damora Therapeutics has reported Treasury Shares for 3 years, with the latest figure at $957513.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares rose 9061.05% year-over-year to $957513.0; the trailing twelve-month figure through Mar 2026 stood at $957513.0 (up 9061.05% YoY), and the FY2025 full-year result was $7800.0, down 50.0% from the prior year.
- Treasury Shares for Q1 2026 stood at $957513.0, up from $7800.0 in the prior quarter.
- The five-year high for Treasury Shares was $957513.0 in Q1 2026, with the low at $7800.0 in Q3 2025.
- Historically, Treasury Shares has averaged $283468.6 across 3 years, with a median of $15600.0 in 2024.
- Annual changes were most pronounced in 2025 — Treasury Shares sank 98.73% — and 2026, when it jumped 9061.05%.
- Damora Therapeutics' Treasury Shares stood at $15600.0 in 2024, then slumped by 50.0% to $7800.0 in 2025, then soared by 12175.81% to $957513.0 in 2026.
- The last three Treasury Shares figures came in at $957513.0 (Q1 2026), $7800.0 (Q4 2025), and $7800.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - | 957,513.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 957,513.00 |
| Mar 31, 2026 | 957,513.00 |
| Dec 31, 2025 | 7,800.00 |
| Dec 31, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Sep 30, 2025 | 7,800.00 |
| Jun 30, 2025 | 10,452.00 |
| Jun 30, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Mar 31, 2025 | 10,452.00 |
| Dec 31, 2024 | 15,600.00 |
| Dec 31, 2024 | 15,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Sep 30, 2024 | 16,600.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 820,000.00 |
| Mar 31, 2024 | 820,000.00 |